Asia · Regional markets · CNBC-TV18

Lupin launches HIV drug in US, secures eligibility for 180-day generic exclusivity

Published by CNBC-TV18 · India 4 h ago

Lupin has launched Raltegravir Tablets USP, 600 mg, in the US after receiving FDA approval. The company is the exclusive first-to-file for the generic version of Merck's Isentress…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

The Straits Times Business

Singapore’s rise as a wealth hub mirrors Asia’s changing fortunes: Julius Baer Asia head

Mint

Corn futures hit four-month low on big US crop, export worries

Business Standard

Markets extend gains for fourth day; FPI buying highest in a year

The Business Times

46,000 SIA booking records accessed illegally in data breach affecting software provider Amadeus

China Daily Business

Wang Yi meets officials from Myanmar, Laos, and Thailand in Beijing

Tech in Asia